tiprankstipranks
Trending News
More News >
QuantumPharm, Inc. (HK:2228)
:2228
Hong Kong Market

QuantumPharm, Inc. (2228) Income Statement

Compare
4 Followers

QuantumPharm, Inc. Income Statement

Last quarter (Q2 2024), QuantumPharm, Inc.'s total revenue was ¥51.31M, a decrease of 0.00% from previous quarter. In Q2, QuantumPharm, Inc.'s net income was ¥-618.51M. See QuantumPharm, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 19
Total Revenue
¥ 266.43M¥ 174.42M¥ 133.35M¥ 62.80M¥ 0.00
Gross Profit
¥ 123.43M¥ 48.24M¥ 66.09M¥ 32.78M¥ 0.00
Operating Expenses
¥ 807.63M¥ 770.55M¥ 582.41M¥ 368.43M¥ 9.88M
Depreciation and Amortization
¥ 83.38M¥ 121.72M¥ 69.05M¥ 23.13M¥ 171.86K
EBITDA
¥ -631.38M¥ -1.78B¥ -390.37M¥ -2.11B¥ -9.84M
Operating Income
¥ -684.21M¥ -722.31M¥ -525.31M¥ -299.43M¥ -9.84M
Other Income/Expenses
¥ -830.66M¥ -1.18B¥ -913.30M¥ -1.84B¥ -13.10M
Pretax Income
¥ -1.51B¥ -1.91B¥ -1.44B¥ -2.14B¥ -22.94M
Net Income
¥ -1.52B¥ -1.91B¥ -1.44B¥ -2.14B¥ -36.03M
Per Share Metrics
Basic EPS
¥ -0.79¥ -0.79¥ -0.59¥ -0.89¥ -0.02
Diluted EPS
¥ -0.79¥ -0.79¥ -0.59¥ -0.89¥ -0.02
Weighted Average Shares Outstanding
1.92B 2.42B 2.42B 2.41B 2.33B
Weighted Average Shares Outstanding (Diluted)
1.93B 2.42B 2.42B 2.41B 2.33B
Currency in CNY

QuantumPharm, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis